Please provide your email address to receive an email when new articles are posted on . Timolol maleate 0.5% microdrops delivered with a volume-reducing adaptor provided noninferior IOP reduction ...

Credit: Getty Images. During the study, 50 migraine patients randomly received either topically applied timolol maleate ophthalmic solution, 0.5%, or placebo eyedrops. Timolol maleate ophthalmic ...

Timolol, a nonselective β-blocker initially approved for glaucoma, shows promise in topical dermatological applications due to its vasoconstrictive, anti-inflammatory, and促进伤口愈合 effects. It has been ...

BERWYN, Pa.--(BUSINESS WIRE)--Amring Pharmaceuticals Inc. (Amring), a niche generic and brand pharmaceutical company, announced today that it has received FDA approval for generic Timolol Maleate ...

Glaukos’ intraocular implant has performed comparably to topical timolol in the 24-month interim analysis of glaucoma patients enrolled in a phase 2b trial. The study is part of Glaukos’ preparations ...